Response to neoadjuvant therapy:PrThr:Pt:Colorectal cancer specimen:Ord:

Preferred Label : Response to neoadjuvant therapy:PrThr:Pt:Colorectal cancer specimen:Ord:;

LOINC status : ACTIVE;

LOINC display name : Response to neoadjuvant therapy Ql (Colorectal cancer specimen);

LOINC long common name : Tumor response to neoadjuvant therapy;

LOINC short name : Tumor resp to neoadjvt therapy;

LOINC description : The response of the tumor to neoadjuvant treatment, such as chemotherapy and radiotherapy. Chemotherapy and/or radiotherapy before resection is associated with significant downstaging and improved prognosis. These specimens require close gross examination and additional blocking to demonstrate tumor. The degree of tumor regression has been shown to correlate with prognosis. This term was created for, but not limited in use to, the Colorectal Cancer Structured Reporting Protocol (2nd Edition, 2012) developed by the Royal College of Pathologists of Australasia (RCPA).;

Détails

Origin ID

84891-1;

UMLS CUI

C4297198;

Has component
- Response to neoadjuvant therapy [LOINC component]
Has property
- Presence or Threshold [LOINC Property]
Has scale
- Ord [LOINC scale]
Has system
- Cancer [LOINC System]
- Cancer specimen [LOINC System]
- Colorectal cancer specimen [LOINC System]
- Specimen [LOINC System]
- ^Cancer [LOINC System]
- ^Specimen [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Cancer pathology panel:-:Pt:Colorectal cancer specimen:-:CAP cancer protocols [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients